Pacific Biosciences of California powers single cell atlas spanning 26 human tissues

Pacific Biosciences of California powers single cell atlas spanning 26 human tissues
PacBio HiFi powers new discoveries

Pacific Biosciences of California has announced new findings supported by PacBio HiFi sequencing, highlighting advancements in rare disease research. Of particular note is a 12.1 percent diagnostic yield in previously unsolved cases, showcasing the impact of the companys sequencing technologies.

Additionally, researchers have developed a single cell atlas that spans 26 human tissues, further demonstrating the reach of HiFi and Kinnex sequencing in biomedical investigation.

Pacific Biosciences of California has recently made its HiFi sequencing platform more accessible to biopharma researchers with the launch of Vega SPRQ-Nx. The company also provided sequencing technology for a global undiagnosed disease hackathon in Singapore, supporting collaborative efforts to address rare and unresolved conditions through innovation, as detailed here. These developments reflect the company's ongoing expansion in life sciences research applications.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.